FES Human Pre-designed siRNA Set A contains three designed siRNAs for FES gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FETUB Human Pre-designed siRNA Set A contains three designed siRNAs for FETUB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FEV Human Pre-designed siRNA Set A contains three designed siRNAs for FEV gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fexofenadine (hydrochloride) (Standard) is the analytical standard of Fexofenadine (hydrochloride). This product is intended for research and analytical applications. Fexofenadine (MDL-16455) hydrochloride is an orally active and nonsedative H1 receptor antagonist. Fexofenadine hydrochloride can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].

Fexofenadine-d3-1 fumarate is deuterated labeled Fexofenadine (HY-B0801). Fexofenadine (MDL-16455) is an orally active and nonsedative H1 receptor antagonist. Fexofenadine can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].

FEZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for FEZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FEZ2 Human Pre-designed siRNA Set A contains three designed siRNAs for FEZ2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FEZF1 Human Pre-designed siRNA Set A contains three designed siRNAs for FEZF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FEZF2 Human Pre-designed siRNA Set A contains three designed siRNAs for FEZF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FFAR1 Human Pre-designed siRNA Set A contains three designed siRNAs for FFAR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FFAR2 Human Pre-designed siRNA Set A contains three designed siRNAs for FFAR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FFAR3 Human Pre-designed siRNA Set A contains three designed siRNAs for FFAR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FFAR4 Human Pre-designed siRNA Set A contains three designed siRNAs for FFAR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGA Human Pre-designed siRNA Set A contains three designed siRNAs for FGA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGA145 is a dual, selective inhibitor for Mpro and human Cathepsin L, with Kis of 3.71 μM, 9.82 μM and 53 nM, for Mal-Mpro, pET21-Mpro and Cathepsin L, respectively. FGA145 reveals a multitarget effects in the antiviral activity[1].

FGB Human Pre-designed siRNA Set A contains three designed siRNAs for FGB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD2 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD3 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD4 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD5 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGD6 Human Pre-designed siRNA Set A contains three designed siRNAs for FGD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF1 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF10 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF11 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF12 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF13 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF14 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF16 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF17 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF18 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF19 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF2 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF20 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF21 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF22 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF23 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF3 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF4 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF5 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF6 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FGF7 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.